Pacific Pharm's Meditoxin eyes bigger market share

Pacific Pharm plans to expand its share of the domestic botulinum toxin market dominated by foreign brands Allergan's Botox, Ipsen's Dysport, Chinese labs' BTX-A - and the market is expected to enter fierce competition.

Meditoxin, the first-domestically-made botulinum toxin type A neurotoxin complex developed by a local start-up Meditox, is challenging the importing brands.

It received ...